[go: up one dir, main page]

Batzios et al., 2011 - Google Patents

P05. 3 N-glycan profile of serum glycoproteins in patients with mucopolysaccharidoses

Batzios et al., 2011

Document ID
11148865241732367005
Author
Batzios S
Chen C
Zafeiriou D
Dewaele S
Fang M
Libert C
Papakonstantinou E
Publication year
Publication venue
European Journal of Paediatric Neurology

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases

Similar Documents

Publication Publication Date Title
Aubourg et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation
Fink et al. Clinical spectrum of Niemann‐Pick disease type C
Bowser et al. Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier
US9597336B2 (en) Therapy for treatment of chronic degenerative brain diseases and nervous system injury
Prows et al. Gaucher disease: enzyme therapy in the acute neuronopathic variant
Rubboli et al. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH 1
Burrow et al. Acute progression of neuromuscular findings in infantile Pompe disease
Kohlschütter et al. Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults
Mansouri et al. Efficacy and safety of miglustat in the treatment of GM2 gangliosidosis: A systematic review
Pérez-Poyato et al. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann–Pick type C disease
Batzios et al. P05. 3 N-glycan profile of serum glycoproteins in patients with mucopolysaccharidoses
Sevin et al. P05. 4 Brain gene therapy for Metachromatic Leukodystrophy: from bench to bedside
Finsterer et al. Progressive mitochondrial Encephalopathy due to the novel compound heterozygous variants c. 182C> T and c. 446A> AG in NARS2: a Case Report
Mikhaylova et al. P05. 5 Clinical phenotype and mutation analysis of Russian patients with Niemann-Pick type C disease
US20190254992A1 (en) Combinations of beta-glycolipides and 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol, compositions and uses thereof in the treatment of disorders associated with protein misfolding and protein aggregations
Kolnikova et al. P05. 1 Efficacy and tolerability of miglustat in patients with Niemann–Pick C disease
Jain et al. Infantile Sandhoff's disease with peripheral neuropathy
Helland et al. P05. 2 Neuronal Ceroid Lipofuscinosis in Norway
Davies et al. P05. 6 Corticospinal Tract Calcification in Krabbe's Disease
Aksoy et al. P04. 13 Coeliac disease mimicing MINGIE
Darras et al. Globoid cell leukodystrophy: cranial computed tomography and evoked potentials
Xu et al. Physiological Factors of Autism
Zafeiriou et al. Serial magnetic resonance imaging and neurophysiological studies in multiple sulphatase deficiency
Valk et al. Globoid Cell Leukodystrophy: Krabbe’s Disease
Sahin et al. Hydrocephalus associated with glycogen storage disease type II (Pompe’s disease)